Epicatechin Prevents Methamphetamine-Induced Neuronal Cell Death via Inhibition of ER Stress

被引:24
作者
Kang, Youra [1 ]
Lee, Ji-Ha [1 ]
Seo, Young Ho [1 ]
Jang, Jung-Hoe [2 ]
Jeong, Chul-Ho [1 ]
Lee, Sooyoun [1 ]
Jeong, Gil-Saeng [1 ]
Park, Byoungduck [1 ]
机构
[1] Keimyung Univ, Coll Pharm, Daegu 42601, South Korea
[2] Keimyung Univ, Sch Med, Dept Pharmacol, Daegu 42601, South Korea
基金
新加坡国家研究基金会;
关键词
Epicatechin; Methamphetamine; Neuroprotection; ENDOPLASMIC-RETICULUM STRESS; LIPID-PEROXIDATION; INDUCED APOPTOSIS; OXIDATIVE STRESS; CANCER-CELLS; ACTIVATION; RECEPTORS; TOXICITY; TRAIL; NEUROTOXICITY;
D O I
10.4062/biomolther.2018.092
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Methamphetamine (METH) acts strongly on the nervous system and damages neurons and is known to cause neurodegenerative diseases such as Alzheimer's and Parkinson's. Flavonoids, polyphenolic compounds present in green tea, red wine and several fruits exhibit antioxidant properties that protect neurons from oxidative damage and promote neuronal survival. Especially, epicatechin (EC) is a powerful flavonoid with antibacterial, antiviral, antitumor and antimutagenic effects as well as antioxidant effects. We therefore investigated whether EC could prevent METH-induced neurotoxicity using HT22 hippocampal neuronal cells. EC reduced METH-induced cell death of HT22 cells. In addition, we observed that EC abrogated the activation of ERK, p38 and inhibited the expression of CHOP and DR4. EC also reduced METH-induced ROS accumulation and MMP. These results suggest that EC may protect HT22 hippocampal neurons against METH-induced cell death by reducing ER stress and mitochondrial damage.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 49 条
  • [1] SCREENING OF TEA CLONES FOR INHIBITION OF PHIP MUTAGENICITY
    APOSTOLIDES, Z
    WEISBURGER, JH
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1995, 326 (02) : 219 - 225
  • [2] Barr AM, 2006, J PSYCHIATR NEUROSCI, V31, P301
  • [3] Expression of Apoptosis Regulating Proteins Identifies Stage II and III Colon Cancer Patients With High Risk of Recurrence
    Belt, Eric J. Th.
    Stockmann, Hein B. A. C.
    Delis-Van Diemen, Pien M.
    Bril, Herman
    Tijssen, Marianne
    Van Essen, Hendrik F.
    Heymans, Martijn W.
    Belien, Jeroen A. M.
    Carvalho, Beatriz
    Cillessen, Saskia A. G. M.
    Meijer, Gerrit A.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (03) : 255 - 265
  • [4] Black tea protects immunocytes from tumor-induced apoptosis by changing Bcl-2/Bax ratio
    Bhattacharyya, A
    Mandal, D
    Lahiry, L
    Sa, G
    Das, T
    [J]. CANCER LETTERS, 2004, 209 (02) : 147 - 154
  • [5] Enzymatic synthesis of substituted epicatechins for bioactivity studies in neurological disorders
    Blount, Jack W.
    Ferruzzi, Mario
    Raftery, Dan
    Pasinetti, Giulio M.
    Dixon, Richard A.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 417 (01) : 457 - 461
  • [6] Curcumin abates hypoxia-induced oxidative stress based-ER stress-mediated cell death in mouse hippocampal cells (HT22) by controlling Prdx6 and NF-κB regulation
    Chhunchha, Bhavana
    Fatma, Nigar
    Kubo, Eri
    Rai, Prerana
    Singh, Sanjay P.
    Singh, Dhirendra P.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2013, 304 (07): : C636 - C655
  • [7] Antioxidant effects of Epicatechin on the hippocampal toxicity caused by Amyloid-beta 25-35 in rats
    Cuevas, Elvis
    Limon, Daniel
    Perez-Severiano, Francisca
    Diaz, Alfonso
    Ortega, Laura
    Zenteno, Edgar
    Guevara, Jorge
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 616 (1-3) : 122 - 127
  • [8] Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment
    Davidson, C
    Gow, AJ
    Lee, TH
    Ellinwood, EH
    [J]. BRAIN RESEARCH REVIEWS, 2001, 36 (01) : 1 - 22
  • [9] Vascular risk factors and cognitive disorders
    Debette, S.
    [J]. REVUE NEUROLOGIQUE, 2013, 169 (10) : 757 - 764
  • [10] Eisch AJ, 1996, SYNAPSE, V22, P217, DOI 10.1002/(SICI)1098-2396(199603)22:3<217::AID-SYN3>3.0.CO